Synthesis of neoclerodane diterpenes and their pharmacological effects.

Salvinorin A, a unique compound, stands out as the first opioid ligand discovered without a basic nitrogen, challenging traditional understanding. Researchers developed sophisticated synthetic methods to recreate and modify its complex structure, which features seven chiral centers. By focusing on specific structural changes, they successfully created new analogs. These efforts yielded promising compounds with diverse and interesting biological activities, highlighting the power of chemical synthesis in drug discovery.

Study at a glance

Abstract

Salvinorin A is a neoclerodane diterpene that has been shown to be an agonist at kappa opioid receptors. Its unique structure makes it an attractive target for synthetic organic chemists due to its seven chiral centers and diterpene scaffold. This molecule is also interesting to pharmacologists because it is a non-serotonergic hallucinogen, and the first opioid ligand discovered that lacks a basic nitrogen. There have been several total synthesis approaches to salvinorin A, and these will be detailed within this chapter. Additionally, research efforts have concentrated on structure modification of the salvinorin A scaffold through semi-synthetic methods. Most modifications have focused on the manipulation of the acetate at C-2 and the furan ring. However, chemistry has also been developed to generate analogs at the C-1 ketone, the C-4 methyl ester, and the C-17 lactone. The synthetic methodologies developed for the salvinorin A scaffold will be described, as well as specific analogs with interesting biological activities.